SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$146,103
+15.1%
97,402
+22.0%
0.00%
Q2 2023$126,939
+27.5%
79,836
-42.4%
0.00%
Q1 2023$99,580
-49.4%
138,607
-59.1%
0.00%
Q4 2022$196,791
-31.0%
339,306
+13.3%
0.00%
Q3 2022$285,000
-42.3%
299,600
-27.4%
0.00%
Q2 2022$494,000
-24.8%
412,590
-17.7%
0.00%
Q1 2022$657,000
-80.2%
501,500
-73.4%
0.00%
Q4 2021$3,318,000
+32.5%
1,885,022
+63.4%
0.00%
Q3 2021$2,504,000
-11.3%
1,153,616
+43.0%
0.00%
Q2 2021$2,824,000
-42.6%
806,891
+61.6%
0.00%
-100.0%
Q1 2021$4,922,000
-63.4%
499,196
-59.7%
0.00%0.0%
Q4 2020$13,438,000
+316.4%
1,239,694
+295.7%
0.00%
Q3 2020$3,227,000
-41.2%
313,255
+19.2%
0.00%
-100.0%
Q2 2020$5,486,000
+210.6%
262,766
+45.4%
0.00%
Q1 2020$1,766,000
-80.6%
180,702
-77.2%
0.00%
-100.0%
Q4 2019$9,114,000
+16.7%
791,139
-44.8%
0.00%
-33.3%
Q3 2019$7,809,000
+94.4%
1,432,857
+324.1%
0.00%
Q2 2019$4,016,000
+3724.8%
337,868
+916.5%
0.00%
Q4 2018$105,000
-74.6%
33,238
-51.3%
0.00%
Q3 2018$413,000
-1.9%
68,300
-14.1%
0.00%
Q2 2018$421,000
-88.7%
79,500
-87.6%
0.00%
-100.0%
Q1 2018$3,726,000
+514.9%
642,412
+270.4%
0.00%
Q4 2017$606,000
+274.1%
173,440
+168.0%
0.00%
Q2 2017$162,000
+1.9%
64,706
+17.9%
0.00%
Q4 2016$159,000
+13.6%
54,881
+23.3%
0.00%
Q2 2016$140,00044,5210.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,043,212$46,578,00047.83%
Soleus Capital Management, L.P. 342,800$3,949,0003.81%
ACUTA CAPITAL PARTNERS, LLC 1,322,500$15,235,0003.77%
RTW INVESTMENTS, LP 6,386,607$73,574,0002.78%
Ghost Tree Capital, LLC 1,175,000$13,536,0002.58%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$5,530,0002.48%
VHCP Management III, LLC 946,234$10,901,0002.16%
Avoro Capital Advisors LLC 5,250,000$60,480,0001.78%
VHCP Management II, LLC 383,620$4,419,0001.16%
Rhenman & Partners Asset Management AB 650,000$7,488,0000.82%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders